GS-US-546-5857

Clinical Trial Grant

Duke Scholars

Principal Investigator Harry Paul Erba Medicine, Hematologic Malignancies and Cellular Therapy

Awarded By

Gilead Sciences, Inc.

Start Date

June 22, 2023

End Date

July 1, 2024

Awarded By

Gilead Sciences, Inc.

Start Date

June 22, 2023

End Date

July 1, 2024